POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company headquartered in Indianapolis, Indiana, with a history spanning nearly 150 years. They are dedicated to discovering and delivering innovative medicines that improve the lives of people around the world. Lilly's mission is to unite caring with discovery to create medicines that make life better, and they work in various therapeutic areas including diabetes, oncology, neurology, and immunology. They have a strong commitment to social impact and prioritize initiatives focused on increasing access to medicines, improving lives and communities, empowering a diverse workforce, and minimizing their environmental footprint.

Lilly is a leader in pharmaceutical innovation and research, consistently investing billions of dollars in research and development. They have a robust clinical trial program, with a commitment to diverse representation to ensure their medicines are effective for all patients. Their commitment to social impact is evident in their extensive charitable work, including the Lilly Foundation, which supports organizations dedicated to improving global health, strengthening communities, and advancing educational opportunities. They also prioritize ethical business practices and strive to operate responsibly, ensuring sustainability across their operations and supply chain.

Eli Lilly and Company is a medicine company dedicated to turning science into healing and improving lives by creating medicines that make life better for people around the world. Their mission is driven by their core values of integrity, excellence, and respect for people, and they are committed to expanding equitable access to medicines for all. They strive to make a positive impact on people, the planet, and society through their responsible and sustainable business practices.

Eli Lilly and Company promotes a culture of caring, discovery, and innovation, placing a strong emphasis on making life better for people around the world. They value integrity, excellence, and respect for people, fostering a diverse and inclusive workforce that welcomes diverse perspectives and experiences. This commitment to diversity, equity, and inclusion extends to their suppliers and is central to their efforts to improve public health and minimize their environmental impact.

Eli Lilly and Company views diversity, equity, and inclusion as fundamental to its business strategy and success. They actively promote a culture that welcomes, respects, and values individual differences, believing that a diverse workforce leads to better decision-making, innovation, and understanding of their diverse patient population. They have established specific goals to increase representation in clinical trials and leadership positions, and they engage in various initiatives, partnerships, and programs to empower underrepresented communities and foster a more inclusive work environment.